Common Contracts
4 similar Underwriting Agreement contracts by Medovex Corp.
MEDOVEX, INC. 1,391,305 Units, each consisting of (i) One Share of Common Stock, $0.001 par value; (ii) One Series A Warrant to Purchase One Share of Common Stock, $0.001 par value; and (iii) One Series B Warrant to purchase one share of Common Stock,...Underwriting Agreement • December 2nd, 2014 • Medovex Corp. • Surgical & medical instruments & apparatus • New York
Medovex, Inc., a Nevada corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the several underwriters (the “Underwriters”) named on Schedule I hereto for whom you are acting as representative (the “Representative”), an aggregate of 1,391,305 units (the “Underwritten Units”) of the Company’s securities. The Company has granted the Underwriters a thirty (30) day option to purchase an aggregate of up to 208,695 additional units (the “Additional Units” and collectively with the Underwritten Units, the “Units”) as may be necessary to cover over-allotments made in connection with the offering. Each Unit consists of one share of the Company’s common stock, par value $0.001 per share (the “Common Stock”), and two warrants (each, a “Series A Warrant and Series B Warrant” and collectively, the “Warrants”). Each Series A Warrant and Series B Warrant entitles the holder to purchase one share of Common Stock. The Units, the shares of Common
MEDOVEX, INC. 1,350,000 Units, each consisting of One Share of Common Stock, $0.001 par value and One Warrant to Purchase One Share of Common Stock, $0.001 par value, and Class B Warrants FORM OF UNDERWRITING AGREEMENTUnderwriting Agreement • November 12th, 2014 • Medovex Corp. • Surgical & medical instruments & apparatus • Florida
Medovex, Inc., a Nevada corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the several underwriters (the “Underwriters”) named on Schedule I hereto for whom you are acting as representative (the “Representative”), an aggregate of 1,350,000 units (the “Underwritten Units”) of the Company’s securities. The Company has granted the Underwriters the option to purchase an aggregate of up to 202,500 additional units (the “Additional Units” and collectively with the Underwritten Units, the “Units”) as may be necessary to cover over-allotments made in connection with the offering. Each Unit consists of one share of the Company’s common stock, par value $0.001 per share (the “Common Stock”), and two warrants (each, a “Series A Warrant and Series B Warrant” and collectively, the “Warrants”). Each Series A Warrant and Series B Warrant entitles the holder to purchase one share of Common Stock. The Units, the shares of Common Stock underlyi
MEDOVEX, INC. _______ Units, each consisting of One Share of Common Stock, $0.001 par value and One Warrant to Purchase One Share of Common Stock, $0.001 par value, and Class B Warrants FORM OF UNDERWRITING AGREEMENTUnderwriting Agreement • October 7th, 2014 • Medovex Corp. • Surgical & medical instruments & apparatus • Florida
Medovex, Inc., a Nevada corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the several underwriters (the “Underwriters”) named on Schedule I hereto for whom you are acting as representative (the “Representative”), an aggregate of [___________] units (the “Underwritten Units”) of the Company’s securities. The Company has granted the Underwriters the option to purchase an aggregate of up to ___________ additional units (the “Additional Units” and collectively with the Underwritten Units, the “Units”) as may be necessary to cover over-allotments made in connection with the offering. Each Unit consists of one share of the Company’s common stock, par value $0.001 per share (the “Common Stock”), and two warrants (each, a “Series A Warrant and Series B Warrant” and collectively, the “Warrants”). Each Series A Warrant and Series B Warrant entitles the holder to purchase one share of Common Stock. The Units, the shares of Common Stock
MEDOVEX, INC. _______ Units, each consisting of One Share of Common Stock, $0.001 par value and One Warrant to Purchase One Share of Common Stock, $0.001 par value, and Class B Warrants FORM OF UNDERWRITING AGREEMENTUnderwriting Agreement • July 8th, 2014 • Medovex Corp. • Surgical & medical instruments & apparatus • Florida
Medovex, Inc., a Nevada corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the several underwriters (the “Underwriters”) named on Schedule I hereto for whom you are acting as representative (the “Representative”), an aggregate of [___________] units (the “Underwritten Units”) and ______ Class B Warrants (the “Underwritten Series B Warrants”) of the Company’s securities. The Company has granted the Underwriters the option to purchase an aggregate of up to ___________ additional units (the “Additional Units” and collectively with the Underwritten Units, the “Units”) and ____ additional Series B Warrants (the “Additional Series B Warrants” and collectively, with Underwritten Series B Warrants the “Series B Warrants”) each as may be necessary to cover over-allotments made in connection with the offering. Each Unit consists of one share of the Company’s common stock, par value $0.001 per share (the “Common Stock”), and one warrant
